• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索苯并[h]色烯衍生物作为抗原生动物和分枝杆菌感染的药物。

Exploring Benzo[h]chromene Derivatives as Agents against Protozoal and Mycobacterial Infections.

作者信息

Pertino Mariano Walter, F de la Torre Alexander, Schmeda-Hirschmann Guillermo, Vega Gómez Celeste, Rolón Miriam, Coronel Cathia, Rojas de Arias Antonieta, Molina-Torres Carmen A, Vera-Cabrera Lucio, Viveros-Valdez Ezequiel

机构信息

Instituto de Química de Recursos Naturales, Universidad de Talca, Campus Lircay, Talca 3480094, Chile.

Department of Medical Physics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.

出版信息

Pharmaceuticals (Basel). 2024 Oct 16;17(10):1375. doi: 10.3390/ph17101375.

DOI:10.3390/ph17101375
PMID:39459014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11510191/
Abstract

In this study, the efficacy of benzo[h]chromene derivatives as antiprotozoal and antimycobacterial agents was explored. A total of twenty compounds, including benzo[h]chromene alkyl diesters and benzo[h]chromene-triazole derivatives, were synthesized and tested against , , , and strains of and LIID-01. Notably, compounds , , , and exhibited superior activity against , with IC values of 19.2, 37.3, 68.7, and 24.7 µM, respectively, outperforming the reference drug benznidazole (IC: 54.7 µM). Compounds and showed excellent selectivity indices against , with SI values of 19 and 18, respectively, suggesting they could be potential alternatives to the commonly used, but more selective, miltefosine (IC: 64.0 µM, SI: 43.0). Additionally, compounds , , and were most effective against , with IC values of 24.9, 30.5, and 46.6 µM, respectively. Compounds and were particularly potent against various strains, highlighting their significance given the inherent resistance of these bacteria to standard antimicrobials. The sensitivity of LIID-01 to these compounds also underscored their potential in managing infections by the Mycobacterium avium-intracellulare complex.

摘要

在本研究中,探索了苯并[h]色烯衍生物作为抗原生动物和抗分枝杆菌剂的功效。总共合成了20种化合物,包括苯并[h]色烯烷基二酯和苯并[h]色烯 - 三唑衍生物,并针对克氏锥虫、杜氏利什曼原虫、鸟分枝杆菌和胞内分枝杆菌菌株以及LIID - 01进行了测试。值得注意的是,化合物3、4、5和6对克氏锥虫表现出优异的活性,IC值分别为19.2、37.3、68.7和24.7 μM,优于参考药物苄硝唑(IC:54.7 μM)。化合物7和8对杜氏利什曼原虫显示出优异的选择性指数,SI值分别为19和18,表明它们可能是常用但选择性更高的米替福新(IC:64.0 μM,SI:43.0)的潜在替代品。此外,化合物9、10和11对鸟分枝杆菌最有效,IC值分别为24.9、30.5和46.6 μM。化合物12和13对各种胞内分枝杆菌菌株特别有效,鉴于这些细菌对标准抗菌药物具有固有抗性,突出了它们的重要性。LIID - 01对这些化合物的敏感性也强调了它们在管理鸟分枝杆菌 - 胞内分枝杆菌复合群感染方面的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fb/11510191/4079b49a5d13/pharmaceuticals-17-01375-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fb/11510191/e8ba468d1d98/pharmaceuticals-17-01375-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fb/11510191/4079b49a5d13/pharmaceuticals-17-01375-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fb/11510191/e8ba468d1d98/pharmaceuticals-17-01375-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1fb/11510191/4079b49a5d13/pharmaceuticals-17-01375-sch001.jpg

相似文献

1
Exploring Benzo[h]chromene Derivatives as Agents against Protozoal and Mycobacterial Infections.探索苯并[h]色烯衍生物作为抗原生动物和分枝杆菌感染的药物。
Pharmaceuticals (Basel). 2024 Oct 16;17(10):1375. doi: 10.3390/ph17101375.
2
Efficacy of a series of alpha-pyrone derivatives against Leishmania (L.) infantum and Trypanosoma cruzi.一系列α-吡喃酮衍生物对婴儿利什曼原虫和克氏锥虫的疗效。
Eur J Med Chem. 2017 Oct 20;139:947-960. doi: 10.1016/j.ejmech.2017.08.055. Epub 2017 Sep 1.
3
Synthesis, trypanocidal and anti-leishmania activity of new triazole-lapachol and nor-lapachol hybrids.新型三氮唑-拉帕醌和去甲拉帕醌杂合体的合成、杀锥虫和抗利什曼原虫活性。
Bioorg Chem. 2020 Oct;103:104122. doi: 10.1016/j.bioorg.2020.104122. Epub 2020 Jul 23.
4
Synthesis and activity of benzimidazole N-Acylhydrazones against Trypanosoma cruzi, Leishmania amazonensis and Leishmania infantum.苯并咪唑 N-酰腙类化合物的合成及抗 Trypanosoma cruzi、Leishmania amazonensis 和 Leishmania infantum 的活性。
Bioorg Med Chem Lett. 2024 Sep 15;110:129876. doi: 10.1016/j.bmcl.2024.129876. Epub 2024 Jul 2.
5
Multitarget anti-parasitic activities of isoquinoline alkaloids isolated from Hippeastrum aulicum (Amaryllidaceae).从孤挺花(石蒜科)中分离得到的异喹啉生物碱的多靶点抗寄生虫活性。
Phytomedicine. 2024 Jun;128:155414. doi: 10.1016/j.phymed.2024.155414. Epub 2024 Feb 5.
6
Hydrazinated geraniol derivatives as potential broad-spectrum antiprotozoal agents.水合香叶醇衍生物作为有潜力的广谱抗寄生虫药物。
Arch Pharm (Weinheim). 2024 Oct;357(10):e2400430. doi: 10.1002/ardp.202400430. Epub 2024 Jul 9.
7
Multi-Anti-Parasitic Activity of Arylidene Ketones and Thiazolidene Hydrazines against Trypanosoma cruzi and Leishmania spp.芳叉基酮和噻唑烷肼对克氏锥虫和利什曼原虫属的多重抗寄生虫活性
Molecules. 2017 May 7;22(5):709. doi: 10.3390/molecules22050709.
8
In vitro antiprotozoal activity and cytotoxicity of extracts and fractions from the leaves, root bark and stem bark of Isolona hexaloba.六裂伊索龙叶、根皮和茎皮提取物及馏分的体外抗原生动物活性和细胞毒性
J Ethnopharmacol. 2015 Nov 4;174:187-94. doi: 10.1016/j.jep.2015.07.034. Epub 2015 Aug 1.
9
Assessment of leishmanicidal and trypanocidal activities of aliphatic diamine derivatives.评估脂肪族二胺衍生物的杀利什曼原虫和杀锥虫活性。
Chem Biol Drug Des. 2013 Dec;82(6):697-704. doi: 10.1111/cbdd.12191. Epub 2013 Aug 10.
10
In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.芳基取代咪唑衍生物作为抗原生动物药物的体外评价以及对克氏锥虫、婴儿利什曼原虫和布氏锥虫的甾醇14α-脱甲基酶(CYP51)的对接研究。
Parasitol Res. 2019 May;118(5):1533-1548. doi: 10.1007/s00436-019-06206-z. Epub 2019 Mar 23.

本文引用的文献

1
Treatment of Resistant Gram-negative bacilli in children.儿童耐药革兰氏阴性杆菌的治疗。
Infect Dis Now. 2023 Nov;53(8S):104794. doi: 10.1016/j.idnow.2023.104794. Epub 2023 Oct 5.
2
Outer Membrane Porins Contribute to Antimicrobial Resistance in Gram-Negative Bacteria.外膜孔蛋白与革兰氏阴性菌的抗菌耐药性有关。
Microorganisms. 2023 Jun 28;11(7):1690. doi: 10.3390/microorganisms11071690.
3
Comprehensive coverage on anti-mycobacterial endeavour reported during 2022.2022 年抗分枝杆菌研究进展综述。
Eur J Med Chem. 2023 Jul 5;255:115409. doi: 10.1016/j.ejmech.2023.115409. Epub 2023 Apr 21.
4
Testing and Treating Mycobacterium tuberculosis Infection.检测和治疗结核分枝杆菌感染。
Med Clin North Am. 2022 Nov;106(6):929-947. doi: 10.1016/j.mcna.2022.08.001.
5
In vitro assessment of 17 antimicrobial agents against clinical Mycobacterium avium complex isolates.体外评估 17 种抗临床鸟分枝杆菌复合体分离株的抗菌药物。
BMC Microbiol. 2022 Jul 8;22(1):175. doi: 10.1186/s12866-022-02582-2.
6
Antibiotic Discovery and Resistance: The Chase and the Race.抗生素的发现与耐药性:追寻与竞赛
Antibiotics (Basel). 2022 Jan 30;11(2):182. doi: 10.3390/antibiotics11020182.
7
Novel Linker Variants of Antileishmanial/Antitubercular 7-Substituted 2-Nitroimidazooxazines Offer Enhanced Solubility.抗利什曼原虫/抗结核的7-取代2-硝基咪唑并恶嗪的新型连接体变体具有更高的溶解度。
ACS Med Chem Lett. 2021 Jan 21;12(2):275-281. doi: 10.1021/acsmedchemlett.0c00649. eCollection 2021 Feb 11.
8
Antituberculosis Activities of Lapachol and β-Lapachone in Combination with Other Drugs in Acidic pH.拉帕醌和β-拉帕醌在酸性 pH 下与其他药物联合的抗结核活性。
Microb Drug Resist. 2021 Jul;27(7):924-932. doi: 10.1089/mdr.2020.0164. Epub 2020 Sep 1.
9
Synthesis, trypanocidal and anti-leishmania activity of new triazole-lapachol and nor-lapachol hybrids.新型三氮唑-拉帕醌和去甲拉帕醌杂合体的合成、杀锥虫和抗利什曼原虫活性。
Bioorg Chem. 2020 Oct;103:104122. doi: 10.1016/j.bioorg.2020.104122. Epub 2020 Jul 23.
10
Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus.非结核分枝杆菌与脓肿分枝杆菌的崛起。
Nat Rev Microbiol. 2020 Jul;18(7):392-407. doi: 10.1038/s41579-020-0331-1. Epub 2020 Feb 21.